InvestSMART

Botanix Pharmaceuticals Ltd (ASX: BOT) - Announcements

- Current share price for BOT : $0.009

ASX company news and announcements for Botanix Pharmaceuticals Ltd (BOT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Botanix Pharmaceuticals Ltd (BOT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Botanix Pharmaceuticals Ltd (BOT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Botanix Pharmaceuticals Ltd (BOT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$25 S&P DJI Announces March 2025 Quarterly Rebalance 7 Mar 2025 5:01PM $0.375 $0.009 fallen by 97.60%
$25 Notification regarding unquoted securities - BOT 7 Mar 2025 1:59PM $0.363 $0.009 fallen by 97.52%
$25 Section 708A(5)(e) Notice 28 Feb 2025 9:48AM $0.455 $0.009 fallen by 98.02%
$25 Change of Director's Interest Notice - S. Washer 28 Feb 2025 9:47AM $0.455 $0.009 fallen by 98.02%
$25 Notification of cessation of securities - BOT 28 Feb 2025 9:44AM $0.455 $0.009 fallen by 98.02%
$25 Application for quotation of securities - BOT 28 Feb 2025 9:43AM $0.455 $0.009 fallen by 98.02%
$25 Appendix 4D and Half Year Report 26 Feb 2025 8:13AM $0.505 $0.009 fallen by 98.22%
$25 December 2024 Quarterly Activities Report and Appendix 4C 31 Jan 2025 9:32AM $0.435 $0.009 fallen by 97.93%
$25 Change of Director's Interest Notice - V. Ippolito 17 Jan 2025 12:08PM $0.473 $0.009 fallen by 98.10%
$25 Change in substantial holding from IFL 15 Jan 2025 9:14AM $0.475 $0.009 fallen by 98.11%
$25 Change of Director's Interest Notice - V. Ippolito 9 Jan 2025 6:28PM $0.455 $0.009 fallen by 98.02%
$25 Application for quotation of securities - BOT 9 Jan 2025 6:15PM $0.455 $0.009 fallen by 98.02%
$25 Notification regarding unquoted securities - BOT 9 Jan 2025 6:12PM $0.455 $0.009 fallen by 98.02%
$25 Ceasing to be a substantial holder 9 Jan 2025 5:56PM $0.455 $0.009 fallen by 98.02%
$25 First Sofdra Prescriptions as Commercialisation Ramps Up 17 Dec 2024 8:18AM $0.380 $0.009 fallen by 97.63%
$25 Change of Director's Interest Notice x 5 3 Dec 2024 8:19PM $0.340 $0.009 fallen by 97.35%
$25 Section 708A(5)(e) Notice 2 Dec 2024 8:21PM $0.350 $0.009 fallen by 97.43%
$25 Notification regarding unquoted securities - BOT 2 Dec 2024 8:19PM $0.350 $0.009 fallen by 97.43%
$25 Application for quotation of securities - BOT 2 Dec 2024 8:16PM $0.350 $0.009 fallen by 97.43%
$25 Botanix Presentation at Bell Potter Healthcare Conference 19 Nov 2024 11:15AM $0.320 $0.009 fallen by 97.19%
$25 Botanix Adds to Payer Coverage 14 Nov 2024 9:41AM $0.320 $0.009 fallen by 97.19%
$25 Results of Annual General Meeting 4 Nov 2024 1:08PM $0.330 $0.009 fallen by 97.27%
$25 Annual General Meeting - Presentation 4 Nov 2024 9:58AM $0.345 $0.009 fallen by 97.39%
$25 Annual General Meeting - Chairman's Address 4 Nov 2024 9:55AM $0.345 $0.009 fallen by 97.39%
$25 September 2024 Quarterly Activities Report and Appendix 4C 28 Oct 2024 9:35AM $0.330 $0.009 fallen by 97.27%

151 - 175 of 726 results

Page 7 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.